Glucagon’s Role in Blood Sugar Regulation: An In-depth Analysis
Abstract: Glucagon, a 29-amino acid peptide hormone, is critical in glucose homeostasis by counteracting insulin to prevent hypoglycemia. This analysis reviews its mechanism, highlighting its role in hepatic glycogenolysis and gluconeogenesis. Within the peptide therapeutics market, glucagon-based products (e.g., nasal, injectable) show distinct pharmacokinetic profiles. Brand comparisons (e.g., GlucaGen vs. Baqsimi) reveal trade-offs in stability, onset speed, and patient compliance. Current industry trends emphasize synthetic peptide purity (>98%) and cold-chain logistics for stability. Regulatory certifications (FDA, EMA) are essential for quality assurance. Selection criteria prioritize bioavailability, storage conditions, and excipient compatibility, guiding clinical and commercial applications.